GOSSAMER BIO INC (GOSS:NASDAQ)
$0.2045 0.0295 (16.8571%)
Analysed GOSSAMER BIO INC (GOSS:NASDAQ) News Sources
Gossamer Bio (GOSS) Stock Fair Value Moves Lower After Mixed Analyst Target Changes
02-07-2026
yahoo.com
Gossamer Bio shares jump after FDA update and seralutinib rights return
27-07-2026
advfn.com
Update: Gossamer Bio Extends Gains Pre-Bell Following New Drug Application Filing Plans for Pulmonary Arterial Hypertension Treatment
28-07-2026
yahoo.com
Gossamer Bio (GOSS) Could Be 96% Undervalued After Its Seralutinib NDA Update
01-08-2026
yahoo.com
Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update
13-08-2026
yahoo.com
Gossamer Bio (GOSS) Stock Sees Fair Value Cut As Analysts Split On Seralutinib
17-08-2026
yahoo.com
Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval
21-08-2026
yahoo.com
Gossamer Bio Agrees to Up to $250 Million Private Placement; Shares Rise Pre-Bell
21-08-2026
yahoo.com
Gossamer Bio Secures Up to $250 Million Private Placement to Fund Seralutinib Through Potential FDA Approval
21-08-2026
advfn.com
Gossamer Bio announces $250m in funding to advance seralutinib
24-08-2026
pharmaceutical-technology.com
What is the current price of GOSSAMER BIO INC (GOSS:NASDAQ)?
The current price of GOSSAMER BIO INC (GOSS:NASDAQ) is $0.2045.
GOSSAMER BIO INC (GOSS:NASDAQ) absolute price change since previous trading day?
The absolute price change of GOSSAMER BIO INC (GOSS:NASDAQ) since the previous trading day is $0.0295.
GOSSAMER BIO INC (GOSS:NASDAQ) percentage price change since previous trading day?
The percentage price change of GOSSAMER BIO INC (GOSS:NASDAQ) since the previous trading day is 16.8571%.
What is the most recent average sentiment score for GOSSAMER BIO INC (GOSS:NASDAQ)?
The most recent average sentiment score for GOSSAMER BIO INC (GOSS:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for GOSSAMER BIO INC (GOSS:NASDAQ)?
The most recent sentiment for GOSSAMER BIO INC (GOSS:NASDAQ) is .
SEC-8K** Filing Available For GOSSAMER BIO INC (GOSS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.